U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915961) titled 'Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients' on March 06.
Brief Summary: To implement a quality improvement plan aimed at achieving a 5% increase in the Forced expiratory volume in 1st second (FEV1) (% predicted value) in cystic fibrosis (CF) patients with impaired pulmonary function parameters over 12 months. Additionally, the plan aims to measure serum human epididymis protein 4 (HE4) levels in the studied subjects before and after pulmonary function improvement.
Study Start Date: Oct. 07, 2024
Study Type: OBSERVATIONAL
Condition:
Cystic Fibrosis (CF)
Recruitmen...